Literature DB >> 24089451

Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.

Federico A Moretti1, Markus Moser, Ruth Lyck, Michael Abadier, Raphael Ruppert, Britta Engelhardt, Reinhard Fässler.   

Abstract

Activated T cells use very late antigen-4/α4β1 integrin for capture, rolling on, and firm adhesion to endothelial cells, and use leukocyte function-associated antigen-1/αLβ2 integrin for subsequent crawling and extravasation. Inhibition of α4β1 is sufficient to prevent extravasation of activated T cells and is successfully used to combat autoimmune diseases, such as multiple sclerosis. Here we show that effector T cells lacking the integrin activator Kindlin-3 extravasate and induce experimental autoimmune encephalomyelitis in mice immunized with autoantigen. In sharp contrast, adoptively transferred autoreactive T cells from Kindlin-3-deficient mice fail to extravasate into the naïve CNS. Mechanistically, autoreactive Kindlin-3-null T cells extravasate when the CNS is inflamed and the brain microvasculature expresses high levels of integrin ligands. Flow chamber assays under physiological shear conditions confirmed that Kindlin-3-null effector T cells adhere to high concentrations of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, albeit less efficiently than WT T cells. Although these arrested T cells polarize and start crawling, only few remain firmly adherent over time. Our data demonstrate that the requirement of Kindlin-3 for effector T cells to induce α4β1 and αLβ2 integrin ligand binding and stabilization of integrin-ligand bonds is critical when integrin ligand levels are low, but of less importance when integrin ligand levels are high.

Entities:  

Keywords:  EAE; integrin affinity

Mesh:

Substances:

Year:  2013        PMID: 24089451      PMCID: PMC3801036          DOI: 10.1073/pnas.1316032110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

Authors:  P P Lee; D R Fitzpatrick; C Beard; H K Jessup; S Lehar; K W Makar; M Pérez-Melgosa; M T Sweetser; M S Schlissel; S Nguyen; S R Cherry; J H Tsai; S M Tucker; W M Weaver; A Kelso; R Jaenisch; C B Wilson
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

2.  Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium.

Authors:  Oliver Steiner; Caroline Coisne; Roméo Cecchelli; Rémy Boscacci; Urban Deutsch; Britta Engelhardt; Ruth Lyck
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

Review 3.  The tail of integrins, talin, and kindlins.

Authors:  Markus Moser; Kyle R Legate; Roy Zent; Reinhard Fässler
Journal:  Science       Date:  2009-05-15       Impact factor: 47.728

4.  Enrichment of distinct microfilament-associated and GTP-binding-proteins in membrane/microvilli fractions from lymphoid cells.

Authors:  Jian-Jiang Hao; Guanghui Wang; Trairak Pisitkun; Genaro Patino-Lopez; Kunio Nagashima; Mark A Knepper; Rong-Fong Shen; Stephen Shaw
Journal:  J Proteome Res       Date:  2008-05-28       Impact factor: 4.466

5.  Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis.

Authors:  R K Bergman; J J Munoz; J L Portis
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

6.  Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation.

Authors:  Craig T Lefort; Jan Rossaint; Markus Moser; Brian G Petrich; Alexander Zarbock; Susan J Monkley; David R Critchley; Mark H Ginsberg; Reinhard Fässler; Klaus Ley
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

7.  Talin-1 and kindlin-3 regulate alpha4beta1 integrin-mediated adhesion stabilization, but not G protein-coupled receptor-induced affinity upregulation.

Authors:  Sharon J Hyduk; Jacob Rullo; Adrianet Puig Cano; Haiyan Xiao; Mian Chen; Markus Moser; Myron I Cybulsky
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

8.  LAD-1/variant syndrome is caused by mutations in FERMT3.

Authors:  Taco W Kuijpers; Edith van de Vijver; Marian A J Weterman; Martin de Boer; Anton T J Tool; Timo K van den Berg; Markus Moser; Marja E Jakobs; Karl Seeger; Ozden Sanal; Sule Unal; Mualla Cetin; Dirk Roos; Arthur J Verhoeven; Frank Baas
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

9.  Demonstration of catch bonds between an integrin and its ligand.

Authors:  Fang Kong; Andrés J García; A Paul Mould; Martin J Humphries; Cheng Zhu
Journal:  J Cell Biol       Date:  2009-06-29       Impact factor: 10.539

10.  Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo.

Authors:  Caroline Coisne; Ruth Lyck; Britta Engelhardt
Journal:  Fluids Barriers CNS       Date:  2013-01-21
View more
  23 in total

1.  Frontline Science: Kindlin-3 is essential for patrolling and phagocytosis functions of nonclassical monocytes during metastatic cancer surveillance.

Authors:  Paola M Marcovecchio; Yanfang Peipei Zhu; Richard N Hanna; Huy Q Dinh; Robert Tacke; Runpei Wu; Sara McArdle; Sophia Reynolds; Daniel J Araujo; Klaus Ley; Catherine C Hedrick
Journal:  J Leukoc Biol       Date:  2020-05-09       Impact factor: 4.962

2.  Ena/VASP proteins regulate activated T-cell trafficking by promoting diapedesis during transendothelial migration.

Authors:  Miriam L Estin; Scott B Thompson; Brianna Traxinger; Marlie H Fisher; Rachel S Friedman; Jordan Jacobelli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

3.  Bioinformatics analysis of an animal model of diet-induced nonalcoholic fatty liver disease with rapid progression.

Authors:  Wei Hong; Tingting Zhang; Junbin Yan; Jianshun Yu; Beihui He; Liyan Wu; Kannan Yao; Wei Mao; Zhiyun Chen
Journal:  Exp Biol Med (Maywood)       Date:  2021-11-13

4.  VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruption.

Authors:  Ana B García-Martín; Pascale Zwicky; Thomas Gruber; Christoph Matti; Federica Moalli; Jens V Stein; David Francisco; Gaby Enzmann; Mitchell P Levesque; Ekkehard Hewer; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-15       Impact factor: 6.200

5.  Kindlin-3 Is Essential for the Resting α4β1 Integrin-mediated Firm Cell Adhesion under Shear Flow Conditions.

Authors:  Ling Lu; ChangDong Lin; ZhanJun Yan; Shu Wang; YouHua Zhang; ShiHui Wang; JunLei Wang; Cui Liu; JianFeng Chen
Journal:  J Biol Chem       Date:  2016-03-18       Impact factor: 5.157

6.  Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches.

Authors:  Peter William Krenn; Steffen Koschmieder; Reinhard Fässler
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

Review 7.  Integrin function in vascular biology: a view from 2013.

Authors:  Edward F Plow; Julia Meller; Tatiana V Byzova
Journal:  Curr Opin Hematol       Date:  2014-05       Impact factor: 3.284

Review 8.  Kindlin-3 in the immune system.

Authors:  Susanna C Fagerholm; Hwee San Lek; Vicky L Morrison
Journal:  Am J Clin Exp Immunol       Date:  2014-02-27

9.  Blocking neutrophil integrin activation prevents ischemia-reperfusion injury.

Authors:  Tadayuki Yago; Brian G Petrich; Nan Zhang; Zhenghui Liu; Bojing Shao; Mark H Ginsberg; Rodger P McEver
Journal:  J Exp Med       Date:  2015-07-13       Impact factor: 14.307

10.  Kindlin-3-mediated integrin adhesion is dispensable for quiescent but essential for activated hematopoietic stem cells.

Authors:  Raphael Ruppert; Markus Moser; Markus Sperandio; Emanuel Rognoni; Martin Orban; Wen-Hsin Liu; Ansgar S Schulz; Robert A J Oostendorp; Steffen Massberg; Reinhard Fässler
Journal:  J Exp Med       Date:  2015-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.